Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

Source:http://linkedlifedata.com/resource/pubmed/id/2404573

Cancer Res. 1990 Feb 1 50 3 606-14

Download in:

View as

General Info

PMID
2404573